However, recent data suggest a calpain-2-mediated cleavage of LIMK1 as a novel RhoA-independent mechanism for LIMK1 activation and CFL-1 phosphorylation in breast cancer cell lines (Rodríguez-Fernández et al., 2021) (Figure 2, right). The gene discussed is CAPN2; the disease is breast cancer.